The North America Urology Laser Market would witness market growth of 5.5% CAGR during the forecast period (2023-2031).
The US market dominated the North America Urology Laser Market by Country in 2023 and would continue to be a dominant market till 2031; thereby, achieving a market value of $406.7 million by 2031. The Canada market is experiencing a CAGR of 7.9% during (2024 - 2031). Additionally, The Mexico market would exhibit a CAGR of 7% during (2024 - 2031).
Urology lasers are advanced medical devices used in urology to diagnose and treat various urinary tract conditions. These lasers utilize focused beams of light to target specific tissues with precision, minimizing damage to surrounding healthy tissue. A significant utilization of these pertains to the management of kidney stones. In this regard, laser lithotripsy fragments stones into more manageable pieces, facilitating their passage or extraction.
Urology lasers are utilized not only for the treatment of kidney stones but also for managing the symptoms of BPH or benign prostatic hyperplasia, a prevalent ailment among elderly males distinguished by an enlarged prostate gland. Patients benefit from the efficacy of laser procedures, including prostate enucleation (ThuLEP) and prostate vaporization (ThuVARP), which reduce prostate tissue, alleviate urinary symptoms, and enhance their quality of life.
The demand for these systems in North America is experiencing a notable surge, driven by several key factors and supported by statistical data. The Kidney Foundation of Canada reported that kidney stones, a prevalent concern in Canada, have shown an increasing trend over the past 25 years, with approximately 12% of men and 6% of women expected to experience a kidney stone during their lifetime. Thus, the increasing prevalence of kidney stones, the burden of NL in certain regions, and the high rates of comorbidities that predispose individuals to urological conditions collectively contribute to the growth of the market in North America.
Based on Laser Type, the market is segmented into Holmium Laser System, Thulium Laser System, Diode Laser System, and Others. Based on Application, the market is segmented into Benign Prostatic Hyperplasia (BPH), Urolithiasis, Non-Muscle-Invasive Bladder Cancer (NMIBC), and Others. Based on countries, the market is segmented into U.S., Mexico, Canada, and Rest of North America.
The US market dominated the North America Urology Laser Market by Country in 2023 and would continue to be a dominant market till 2031; thereby, achieving a market value of $406.7 million by 2031. The Canada market is experiencing a CAGR of 7.9% during (2024 - 2031). Additionally, The Mexico market would exhibit a CAGR of 7% during (2024 - 2031).
Urology lasers are advanced medical devices used in urology to diagnose and treat various urinary tract conditions. These lasers utilize focused beams of light to target specific tissues with precision, minimizing damage to surrounding healthy tissue. A significant utilization of these pertains to the management of kidney stones. In this regard, laser lithotripsy fragments stones into more manageable pieces, facilitating their passage or extraction.
Urology lasers are utilized not only for the treatment of kidney stones but also for managing the symptoms of BPH or benign prostatic hyperplasia, a prevalent ailment among elderly males distinguished by an enlarged prostate gland. Patients benefit from the efficacy of laser procedures, including prostate enucleation (ThuLEP) and prostate vaporization (ThuVARP), which reduce prostate tissue, alleviate urinary symptoms, and enhance their quality of life.
The demand for these systems in North America is experiencing a notable surge, driven by several key factors and supported by statistical data. The Kidney Foundation of Canada reported that kidney stones, a prevalent concern in Canada, have shown an increasing trend over the past 25 years, with approximately 12% of men and 6% of women expected to experience a kidney stone during their lifetime. Thus, the increasing prevalence of kidney stones, the burden of NL in certain regions, and the high rates of comorbidities that predispose individuals to urological conditions collectively contribute to the growth of the market in North America.
Based on Laser Type, the market is segmented into Holmium Laser System, Thulium Laser System, Diode Laser System, and Others. Based on Application, the market is segmented into Benign Prostatic Hyperplasia (BPH), Urolithiasis, Non-Muscle-Invasive Bladder Cancer (NMIBC), and Others. Based on countries, the market is segmented into U.S., Mexico, Canada, and Rest of North America.
List of Key Companies Profiled
- Olympus Corporation
- Biolitec AG
- Stryker Corporation
- Boston Scientific Corporation
- Richard Wolf GmbH
- Cook Medical, Inc.(Cook Group)
- Karl Storz SE & Co. KG
- OmniGuide, Inc.
- Allengers Medical Systems Ltd.
- Becton, Dickinson and Company
Market Report Segmentation
By Laser Type- Holmium Laser System
- Thulium Laser System
- Diode Laser System
- Others
- Benign Prostatic Hyperplasia (BPH)
- Urolithiasis
- Non-Muscle-Invasive Bladder Cancer (NMIBC)
- Others
- US
- Canada
- Mexico
- Rest of North America
Table of Contents
Chapter 1. Market Scope & Methodology
Chapter 2. Market at a Glance
Chapter 3. Market Overview
Chapter 4. North America Urology Laser Market by Laser Type
Chapter 5. North America Urology Laser Market by Application
Chapter 6. North America Urology Laser Market by Country
Chapter 7. Company Profiles
Companies Mentioned
- Olympus Corporation
- Biolitec AG
- Stryker Corporation
- Boston Scientific Corporation
- Richard Wolf GmbH
- Cook Medical, Inc.(Cook Group)
- Karl Storz SE & Co. KG
- OmniGuide, Inc.
- Allengers Medical Systems Ltd.
- Becton, Dickinson and Company
Methodology
LOADING...
